Diabetes, Digestive, and Kidney Diseases Extramural Research in Arizona
Diabetes, Digestive, and Kidney Diseases Extramural Research (93.847) awarded $88.8 million to recipients in Arizona in 70 grants from fiscal 2021 to 2025, 0.9% of the program's national total. University of Arizona received the most, $49.8 million.
- Awarded in Arizona$88.8 million
- Awards70
- Share of the program0.9%
- Rank among states24th of 51
- National total$9.6 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 25 | $9.2 million |
| FY 2022 | 33 | $15.7 million |
| FY 2023 | 39 | $17.2 million |
| FY 2024 | 44 | $22.9 million |
| FY 2025 | 41 | $23.8 million |
Recipients in Arizona
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| University of Arizona | Colleges and universities | 39 | $49.8 million |
| Arizona State University | Colleges and universities | 12 | $16.7 million |
| Mayo Clinic Arizona | Nonprofits | 7 | $8.8 million |
| The Translational Genomics Research Institute | Nonprofits | 3 | $7.8 million |
| Ceria Therapeutics Inc | Small businesses | 2 | $2.3 million |
| Immunoshield Therapeutics Inc. | Small businesses | 2 | $1.2 million |
| Faknostics LLC | Small businesses | 1 | $989,753 |
| Dignity Health | Nonprofits | 2 | $464,942 |
| Endotat Biotechnologies LLC | Small businesses | 1 | $343,000 |
| Procyon Technologies LLC | Small businesses | 1 | $299,968 |
Open opportunities under this program
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Single Source for the Continuation of the Physiology of the Weight Reduced State (POWERS) Study (U01- Clinical Trials Required)
- NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- Diabetes Research Centers (P30 Clinical Trial Optional)
- Silvio O. Conte Digestive Diseases Research Core Centers (P30-Clinical Trial Optional)
- Continuation of the Cardiovascular Repository for-Type 1 Diabetes (CARE-T1D) Consortium U01 (Open Competition)- Research (U01, Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
See all 64 on the program page
Questions people ask
How much Diabetes, Digestive, and Kidney Diseases Extramural Research money goes to Arizona?
$88.8 million from fiscal 2021 to 2025, across 70 awards. Arizona ranks 24th of 51 states and territories for this program.
Who receives Diabetes, Digestive, and Kidney Diseases Extramural Research money in Arizona?
The largest recipient is University of Arizona, with $49.8 million in 39 awards. Next are Arizona State University and Mayo Clinic Arizona.
Can organizations in Arizona apply now?
Yes, 64 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Diabetes, Digestive, and Kidney Diseases Extramural Research in other states
Other large programs in Arizona
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- National School Lunch Program
- Child Care and Development Block Grant
- Title I Grants to Local Educational Agencies
- Children's Health Insurance Program
- Head Start
- Temporary Assistance for Needy Families
- Special Education Grants to States